Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
Journal of cancer research and clinical oncology
Year: 2013, Jahrgang: 139, Heft: 2, Pages: 337-345 |
| ISSN: | 0171-5216 |
| Online-Zugang: |
|
| Verfasserangaben: | Gencer, Deniz ... Hofheinz, Ralf-Dieter |
| ISSN: | 0171-5216 |
|---|